The role of body mass index in survival outcome for lymphoma patients: US intergroup experience

F. Hong, T. M. Habermann, L. I. Gordon, H. Hochster, R. D. Gascoyne, V. A. Morrison, R. I. Fisher, N. L. Bartlett, P. J. Stiff, B. D. Cheson, M. Crump, S. J. Horning, B. S. Kahl

Research output: Contribution to journalArticlepeer-review

30 Scopus citations


BBackground: The role of body mass index (BMI) in survival outcomes is controversial among lymphoma patients. We evaluated the association between BMI at study entry and failure-free survival (FFS) and overall survival (OS) in three phase III clinical trials, among patients with diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL) and Hodgkin's lymphoma (HL). Patients and methods: A total of 537, 730 and 282 patients with DLBCL, HL and FL were included in the analysis. Baseline patient and clinical characteristics, treatment received and clinical outcomes were compared across BMI categories. Results: Among patients with DLBCL, HL and FL, the median age was 70, 33 and 56; 29%, 29% and 37% were obese and 38%, 27% and 37% were overweight, respectively. Age was significantly different among BMI groups in all three studies. Higher BMI groups tended to have more favorable prognosis factors at study entry among DLBCL and HL patients. BMI was not associated with clinical outcome with P-values of 0.89, 0.30 and 0.40 for FFS, and 0.64, 0.67 and 0.09 for OS, for patients with DLBCL, HL and FL, respectively. The association remains non-significant after adjusting for other clinical factors in the Cox model. A subset analysis of males with DLBCL treated on R-CHOP revealed no differences in FFS (P = 0.48) or OS (P = 0.58). Conclusion: BMI was not significantly associated with clinical outcomes among patients with DLBCL, HD or FL, in three prospective phase III clinical trials. The findings contradict some previous reports of similar investigations. Further work is required to understand the observed discrepancies.

Original languageEnglish (US)
Article numbermdt594
Pages (from-to)669-674
Number of pages6
JournalAnnals of Oncology
Issue number3
StatePublished - Mar 2014


  • Body mass index
  • Diffuse large B-cell lymphoma
  • Follicular lymphoma
  • Hodgkin's lymphoma
  • Survival outcomes

ASJC Scopus subject areas

  • Hematology
  • Oncology


Dive into the research topics of 'The role of body mass index in survival outcome for lymphoma patients: US intergroup experience'. Together they form a unique fingerprint.

Cite this